HomeNew
Latest
E-paper
Companies
Economy
Finance
Budget
Industry
Markets
External Affairs Defence Security
World News
Opinion
India News
Technology
Specials
Partner Content
Multimedia
sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
NewslettersNew
Video Gallery
WebstoriesNew
Politics
Management
Sudoku
Crossword
BS Apps
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Don’t miss the latest developments in business and finance.
Eris Lifesciences buys dermatology brands from Dr Reddy's for Rs 275 crore
In January Eris had bought some derma brands from Glenmark Pharma as well
Eris Lifesciences Ltd buys 9 dermatology brands from Dr Reddy's for $33 mn
Eris and Dr. Reddy's did not immediately respond to Reuters' requests seeking the names of the dermatology brands
Expensive deal valuations to hit Torrent Pharma's near-term earnings
Sales trajectory in domestic formulations and resolution of regulatory issues are other triggers
Rise of cosmetic dermatology space gets big pharma looking for buyouts
According to reports, Torrent Pharmaceuticals is set to sign a deal to acquire Curatio Healthcare, a maker of skincare products, for Rs 2100 crore.
Eris acquires Oaknet Healthcare for Rs 650 cr for dermatology foray
With a revenue base of Rs 195 crore in FY22, Oaknet brings a portfolio of leading brands in dermatology and women's health to the Eris stable.
Tedious road to recovery: Covid is also altering people's signatures
Children, too, are experiencing aftereffects such as sleeplessness, fatigue, brain fog
Herpes, hair fall, nail issues: Doctors caution about post-Covid problems
From reactivation of herpes infection to loss of hair, several Covid patients in recovery phase are facing one dermatological complication or another due to lowered immunity, say doctors
Asset monetisation, sales uptick in US key triggers for Glenmark Pharma
The India business is expected to post double digit growth in FY22
Lockdown serves domestic pharma the bitter pill: April growth slips
Lack of fresh prescriptions drags growth in acute therapies
Rs 8,700 cr dermatology market is the new king in the pharma sector
Changing climatic conditions, higher pollution and increasing disposable incomes have contributed to the growth